This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron Highlights Its Innovative Body Shaping Products In Conjunction With The BODY Conference And Exhibition In London

LONDON, November 5, 2012 /PRNewswire/ --

Syneron Medical Ltd. (NASDAQ: ELOS),, the leading global aesthetic device company, announced to a group of international media its new activities and enhanced global commitment to developing the non-invasive body shaping market, one of the fastest growing segments in the global aesthetic medical device market. The press conference took place at the Academy of Medical Sciences in London, just prior to the opening of the BODY Conference and Exhibition (, which took place in London on November 3-4, 2012 and for which Syneron was the main sponsor.

To view the Multimedia News Release, please click:

At the press conference, Syneron's Founder and Chairman of the Board, Shimon Eckhouse, Ph.D., and Syneron's Chief Executive Officer, Louis Scafuri provided an overview of Syneron's innovative technologies addressing the body shaping market as well as data on the market size and trends. The technologies presented included the Company's market leading UltraShape ® and VelaShape ® product lines. UltraShape was the first minimally invasive fat destructive system and features proprietary focused ultrasound technology. VelaShape, with an installed base of more than 7,000 systems worldwide, was the first non-invasive body shaping device and features Syneron's proprietary elōs technology. Together, these complementary product lines are the basis for Syneron's global leadership position and state-of-the-art know-how with regards to non-invasive body shaping treatments.

As the leader with over 10 years of experience in treating both superficial fat and cellulite, Syneron has accumulated vast clinical information to safely and effectively meet consumer needs and desires. During the press conference, Syneron reviewed its on-going multi-center clinical trials and research activities focused on body shaping technologies. These investments highlight the Company's commitment to "Science - Results - Trust" in its efforts to develop the technology behind all of its products.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs